Skip to main content

Advertisement

Log in

The relationships between titers of anti-Ro or anti-La as measured by ELISA and salivary production rate with age correction

  • Original Article
  • Published:
Modern Rheumatology

Abstract

The objective of this work was to clarify the clinical significance of titers of anti-Ro and anti-La, the relationships between titers of either anti-Ro or anti-La, and salivary production rate (SPR). These autoantibodies were titrated using enzyme-linked immunosorbent assay. The Saxon test was performed to measure SPR. Fifty-one females who had anti-Ro but not anticentromere antibodies or anti-U1RNP were enrolled. SPR decreased significantly with age. In order to exclude the effect of aging on SPR, we calculated the “SPR with age correction.” According to the results of a multiple regression analysis, only the anti-La titer was significantly associated with SPR with age correction. The distribution pattern of the anti-La titers consisted of two subgroups (with a titer index cutoff of 100.0): a negative anti-La titer (anti-La < 25.0) and low anti-La titer (25.0 ≤ anti-La < 100.0) group, and a high anti-La titer group (anti-La ≥ 100.0). The concentration of serum IgG and the frequency of Sjögren’s syndrome in the high anti-La titer group were significantly higher than those in the negative anti-La and low anti-La titer group. Several new aspects of the clinical significance of titrating anti-Ro and anti-La in comparison with SPR have been revealed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bell M, Askari A, Bookman A, Frydrych S, Lamont J, McComb J, et al. Sjögren’s syndrome: a critical review of clinical management. J Rheumatol. 1999;26:2051–61.

    PubMed  CAS  Google Scholar 

  2. Takada K, Suzuki K, Okada M, Nakashima M, Ohsuzu F. Salivary production rates fall with age in subjects having anticentromere, anti-Ro, and/or anti-La antibodies. Scand J Rheumatol. 2006;35:23–8.

    Article  PubMed  CAS  Google Scholar 

  3. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol. 2005;32:1488–94.

    PubMed  Google Scholar 

  4. Katano K, Kawano M, Koni I, Sugai S, Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sjögren’s syndrome. J Rheumatol. 2001;28:2238–44.

    PubMed  CAS  Google Scholar 

  5. Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, et al. Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006;54:2243–9.

    Article  PubMed  CAS  Google Scholar 

  6. Takada K, Suzuki K, Matsumoto M, Okada M, Nakanishi T, Horikoshi H, et al. Negative correlation of anti-U1RNP antibody titers and the amount of salivary secretion with age correction. Intern Med. 2008;47:385–90.

    Article  PubMed  Google Scholar 

  7. Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J Rheumatol. 1991;18:1511–9.

    PubMed  CAS  Google Scholar 

  8. Ramos-Casals M, Nardi N, Brito-Zeron P, Aguilo S, Gil V, Delgado G, et al. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum. 2006;35:312–21.

    Article  PubMed  CAS  Google Scholar 

  9. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.

    Article  PubMed  CAS  Google Scholar 

  10. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren’s syndrome (1999): availability and validity. Mod Rheumatol. 2004;14:425–34.

    Article  Google Scholar 

  11. Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity. 2005;38:55–63.

    Article  PubMed  CAS  Google Scholar 

  12. Touloupi E, Routsias JG, Tzioufas AG. Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients. Clin Exp Immunol. 2005;142:172–9.

    Article  PubMed  CAS  Google Scholar 

  13. Hassan AB, Lundberg IE, Isenberg D, Wahren-Herlenius M. Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scand J Rheumatol. 2002;31(3):133–9.

    Article  PubMed  Google Scholar 

  14. Yoshida S, Kojima L, Taguchi H, Takeda H, Torigai K. Measurement of anti-SS-A/Ro antibody and anti-SS-B/La antibody by MESACUP-2 test SS-A and SS-B. Igaku To Yakugaku (in Japanese). 2001;45:137–46.

  15. Kohler PF, Winter ME. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum. 1985;28:1128–32.

    Google Scholar 

  16. Workshop on diagnostic criteria for Sjögren’s syndrome. I. Questionnaires for dry eye and dry mouth. II. Manual of method and procedures. Clin Exp Rheumatol. 1989;7:212–9.

    Google Scholar 

  17. Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, Isenberg D, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis. 2004;63:1155–8.

    Article  PubMed  CAS  Google Scholar 

  18. Goren MB, Goren SB. Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol. 1988;106:570–4.

    Article  PubMed  CAS  Google Scholar 

  19. Tsubota K. The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol. 1991;111:106–8.

    PubMed  CAS  Google Scholar 

  20. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis. 1998;57:20–4.

    Article  PubMed  CAS  Google Scholar 

  21. Tengnér P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren’s syndrome. Arthritis Rheum. 1998;41:2238–48.

    Article  PubMed  Google Scholar 

  22. Pillimer SR. Sjögren’s syndrome. In: Klippel JH, editor. Primer on the rheumatic diseases, 12th ed. Atlanta: The Arthritis Foundation; 2001. p. 377–84.

  23. Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren’s syndrome: findings in humans and mice. Arthritis Rheum. 2008;58:734–43.

    Article  PubMed  CAS  Google Scholar 

  24. Halse AK, Marthinussen MC, Wahren-Herlenius M, Jonsson R. Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren’s syndrome. Scand J Rheumatol. 2000;29:13–9.

    PubMed  CAS  Google Scholar 

  25. Tsuzaka K, Ogasawara T, Tojo T, Fujii H, Tsukatani Y, Kubo A, et al. Relationship between autoantibodies and clinical parameters in Sjögren’s syndrome. Scand J Rheumatol. 1993;22:1–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

We declare that there is no conflict of interest in this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kunio Takada.

About this article

Cite this article

Takada, K., Suzuki, K., Matsumoto, M. et al. The relationships between titers of anti-Ro or anti-La as measured by ELISA and salivary production rate with age correction. Mod Rheumatol 18, 578–584 (2008). https://doi.org/10.1007/s10165-008-0098-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-008-0098-0

Keywords

Navigation